Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 62 checked references that resolve
resolves10.1002/jcp.21986High glucose increases expression of cyclooxygenase‐2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells
resolves10.1002/jcp.21063Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells
resolves10.1542/peds.2003-0649-FInsulin Sensitivity Among Obese Children and Adolescents, According to Degree of Weight Loss
resolves10.1101/gad.17420111AMP-activated protein kinase—an energy sensor that regulates all aspects of cell function
resolves10.1111/jcpt.12379Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013
resolves10.7326/0003-4819-151-4-200908180-00136The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
resolves10.4161/cc.11.2.18813Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
resolves10.7150/ijbs.29689Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2
resolves10.1186/s13046-019-1090-6Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways
resolves10.3390/cancers11020209Metformin Treatment Suppresses Melanoma Cell Growth and Motility Through Modulation of microRNA Expression
resolves10.1371/journal.pone.0192759Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer
resolves10.1016/j.bbagen.2014.01.023The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
resolves10.1186/s12943-017-0701-0Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
resolves10.1093/humrep/des203Cleavage of endometrial -integrins into their functional forms is mediated by proprotein convertase 5/6
resolves10.1126/science.1120781The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
resolves10.1016/j.cmet.2004.12.003AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
resolves10.1530/ERC-15-0402Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
resolves10.1038/381800a0Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
resolves10.1111/1751-2980.12576Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle‐related proteins
resolves10.1111/dom.13262Epigenetic effects of metformin: From molecular mechanisms to clinical implications
resolves10.1016/j.biopha.2018.03.008Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells
resolves10.1007/s13410-017-0558-1Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes
resolves10.3390/ijms17122000Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells
resolves10.1158/1940-6207.CAPR-14-0348Prevention of Tumor Growth Driven by
<i>PIK3CA</i>
and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
resolves10.7314/APJCP.2012.13.7.3275Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway
resolves10.1038/cddis.2011.86Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
resolves10.1002/ijc.28149Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells
resolves10.1186/s12885-018-4344-3Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
resolves10.1530/ERC-15-0243Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial
resolves10.18632/oncotarget.6373Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
resolves10.1089/hum.2018.048Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
resolves10.1016/j.gene.2018.04.045Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway
resolves10.4161/cc.20948Metformin is synthetically lethal with glucose withdrawal in cancer cells
resolves10.1158/0008-5472.CAN-08-2689Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
resolves10.1038/oncsis.2015.18Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
resolves10.1038/cddis.2010.31Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes
resolves10.1074/jbc.RA118.001824Endoplasmic reticulum (ER) stress–induced reactive oxygen species (ROS) are detrimental for the fitness of a thioredoxin reductase mutant
resolves10.1371/journal.pone.0174486Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner
resolves10.1038/onc.2011.495Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
The 12 references without a DOI — listed, not checked
no DOI — not checkedWexlerDJ. Initial management of blood glucose in adults with type 2 diabetes mellitus. NathanMD (Ed.). UpToDate (2019).
no DOI — not checkedCrowleyMJ DiamantidisCJ McDuffieJRet al.Metformin use in patients with historical contraindications or precautions. Department of Veterans Affairs (US) DC USA (2016). www.ncbi.nlm.nih.gov/books/NBK409374/
no DOI — not checkedDigitalN. Increase in prescriptions for diabetes exceeds rise in overall prescribing (2017). www.digital.nhs.uk
no DOI — not checkedSharmaM , NazarethI , PetersenI. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open2016(6), 10–12; e010210 (2015).
no DOI — not checkedAromatarisE MunnZ (Eds). Chapter 1: JBI Systematic Reviews. In: Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute (2017).
no DOI — not checkedLuCC , ChiangJH , TsaiFJet al.Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. Int. J. Oncol.54(4), 1271–1281 (2019).
no DOI — not checkedStevenC PlaxeAJM. Overview of endometrial carcinomaGoffD DizonDS VoraSR FalkSJ (Eds). USA (2019).
no DOI — not checkedMcCullochDavid K. Metformin in the treatment of adults with type 2 diabetes mellitus. FunnellM (Ed.). Sourcebook Inc. IL USA Topic 1809 Version 40.0 (2018).
no DOI — not checkedHeY , TanX , HuHet al.Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway. Oncol. Lett.15(3), 2939–2945 (2018).
no DOI — not checkedLiZ , WangL , LuoNet al.Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt. Oncol. Lett.15(5), 7948–7954 (2018).
no DOI — not checkedAljofanM , LoMK , RotaPA , MichalskiWP , MungallBA. Off label antiviral therapeutics for henipaviruses: new light through old windows. J. Antivir. Antiretrovir.2(1), 1–10 (2010).
no DOI — not checkedSuT , LiaoB , DongYet al.Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis. Zhonghua Wei Chang Wai Ke Za Zhi20(6), 689–693 (2017).
checked 2026-07-24 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.